EPC Form 4: Executive Exit Triggers Share Disposition and Award Forfeitures

Rhea-AI Filing Summary

Edgewell Personal Care insider filing shows executive departure and resulting equity changes. The Form 4 reports that Daniel Sullivan, the company's Chief Operating Officer, departed on October 1, 2025, triggering the disposition and forfeiture of equity awards. The filing records a disposition of 90,418 shares of common stock and notes that several unvested awards were forfeited upon departure. The form also lists multiple vested stock options and restricted stock equivalents that remained exercisable or convertible after departure, with holders typically having 90 days to exercise vested options. The filing is signed by an attorney-in-fact on October 2, 2025 and includes detailed counts and exercise prices for each option and award.

Positive

• Vested options retained: multiple vested option tranches remain exercisable within the standard 90-day post-departure window
• Detailed disclosure: form provides explicit counts and exercise prices for each option and award enabling clear tracking

Negative

• Disposition of 90,418 shares: reporting person sold or otherwise disposed of 90,418 shares of common stock
• Forfeiture of unvested awards: multiple unvested awards were forfeited upon Mr. Sullivan's departure (counts listed in the filing)

Insights

Corporate Governance Specialist

TL;DR: Departure of a C-suite officer with immediate equity disposition and forfeitures.

The filing documents Daniel Sullivan's departure on October 1, 2025, and an associated sale/disposition of 90,418 shares of common stock. It also records the forfeiture of multiple unvested awards tied to his employment termination. For investors, the key governance signal is an executive exit that prompted automatic equity-accounting actions defined by the company’s award agreements.

Equity Compensation Analyst

TL;DR: Vested awards remain exercisable; numerous unvested awards were forfeited.

The Form 4 lists several vested stock-option tranches and restricted stock equivalents that remain exercisable or convertible and notes a standard 90-day exercise window following departure for vested options. The filing itemizes forfeited unvested awards (counts shown in the form) and lists vested option quantities and exercise prices that the reporting person can still exercise within the post-termination period.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Sullivan Daniel

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								90,418	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Options 11-11-2022	$39.75	10/01/2025		J	V		6,132(1)	11/11/2023	11/11/2032	Common Stock	6,132	$0	12,265(2)	D
Non-Qualified Stock Options 11/12/2021	$43.29	10/01/2025		J	V		0	11/12/2022	11/12/2031	Common Stock	0	$0	16,428(3)	D
Non-Qualified Stock Options 11/13/2020	$35.37	10/01/2025		J	V		0	11/13/2021	11/13/2030	Common Stock	0	$0	8,857(3)	D
Non-Qualified Premium Stock Options 11/13/2020	$38.91	10/01/2025		J	V		0	11/13/2021	11/13/2030	Common Stock	0	$0	18,535(3)	D
Non-Qualified Stock Options 11/14/2019	$31.44	10/01/2025		J	V		0	11/14/2020	11/14/2029	Common Stock	0	$0	23,580(3)	D
Non-Qualified Stock Options 11/10/2023	$34.22	10/01/2025		J	V		13,848(1)	11/10/2024	11/10/2033	Common Stock	13,848	$0	6,924(2)	D
Restricted Stock Equivalent 11/11/2022	$0	10/01/2025		J	V		3,522(1)	11/11/2023	11/11/2025	Common Stock	3,522	$0	0	D
Restricted Stock Equivalent 11/10/2023	$0	10/01/2025		J	V		8,182(1)	11/10/2024	11/10/2026	Common Stock	8,182	$0	0	D
Restricted Stock Equivalent 11/8/2024	$0	10/01/2025		J	V		17,700(1)	11/08/2025	11/08/2027	Common Stock	17,700	$0	0	D
Performance Restricted Stock Equivalent 11/11/2022	$0	10/01/2025		J	V		35,221(1)	11/11/2025	11/11/2025	Common Stock	35,221	$0	0	D
Performance Restricted Stock Equivalent 11/10/2023	$0	10/01/2025		J	V		40,912(1)	11/10/2026	11/10/2026	Common Stock	40,912	$0	0	D
Performance Restricted Stock Equivalent 11/8/2024	$0	10/01/2025		J	V		53,098(1)	11/11/2027	11/11/2027	Common Stock	53,098	$0	0	D

Explanation of Responses:

1. Unvested award forfeited upon Mr. Sullivan's departure from the Company on October 1, 2025.

2. These options were vested prior to Mr. Sullivan's departure from the Company. He has 90 days from his departure date to exercise them.

3. There were no unvested options for this award to forfeit at the time of Mr. Sullivan's departure from the Company. This is the number of vested and exercisable options that he has 90 days to exercise from the date of his departure.

	/s/ LaTanya Langley, Attorney-in-Fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Daniel Sullivan report on the Form 4 for EPC?

The Form 4 reports Mr. Sullivan's departure on October 1, 2025, a disposition of 90,418 shares, and the forfeiture of several unvested equity awards.

Does Mr. Sullivan keep any equity after leaving EPC (EPC)?

Yes. The filing lists multiple vested stock options and restricted stock equivalents that remain exercisable or convertible; vested options generally have a 90-day exercise window from the departure date.

Which unvested awards were forfeited upon departure?

The filing's Explanation notes that unvested awards identified with footnote (1) were forfeited upon Mr. Sullivan's departure; the form lists those awards and their share counts.

What is the exercise period for vested options after Mr. Sullivan’s departure?

The Form 4 states vested options were exercisable and that Mr. Sullivan has 90 days from his departure date to exercise them.

When was the Form 4 signed and filed?

The Form 4 is signed by LaTanya Langley, Attorney-in-Fact, on October 2, 2025.